# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1167859 | F | Antiviral activity against Coxsackievirus B3 infected in african green monkey Virus assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS assay | Coxsackievirus B3 | 38 | organism-based format | Scientific Literature | ||
2. | ALA1167860 | A | Cytotoxicity against african green monkey Vero cells after 3 days by MTS assay | Chlorocebus sabaeus | 38 | cell-based format | Scientific Literature | ||
3. | ALA1662992 | F | Antiviral activity against Human rhinovirus 86 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus B86 | 2 | organism-based format | Scientific Literature | ||
4. | ALA1662993 | F | Antiviral activity against Human rhinovirus 85 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus A85 | 2 | organism-based format | Scientific Literature | ||
5. | ALA1662994 | F | Antiviral activity against Human rhinovirus 72 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus B72 | 2 | organism-based format | Scientific Literature | ||
6. | ALA1662995 | F | Antiviral activity against Human rhinovirus 70 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus B70 | 2 | organism-based format | Scientific Literature | ||
7. | ALA1662996 | F | Antiviral activity against Human rhinovirus 63 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus A63 | 2 | organism-based format | Scientific Literature | ||
8. | ALA1662997 | F | Antiviral activity against Human rhinovirus 45 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus A45 | 2 | organism-based format | Scientific Literature | ||
9. | ALA1662998 | F | Antiviral activity against Human rhinovirus 42 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | Human rhinovirus 42 | 2 | cell-based format | Scientific Literature | ||
10. | ALA1662999 | F | Antiviral activity against Human rhinovirus 41 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus A41 | 2 | organism-based format | Scientific Literature | ||
11. | ALA1663000 | F | Antiviral activity against Human rhinovirus 39 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus A39 | 2 | organism-based format | Scientific Literature | ||
12. | ALA1663001 | F | Antiviral activity against Human rhinovirus 15 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus A15 | 2 | organism-based format | Scientific Literature | ||
13. | ALA1663002 | F | Antiviral activity against Human rhinovirus 14 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus B14 | 2 | organism-based format | Scientific Literature | ||
14. | ALA1663003 | F | Antiviral activity against Human rhinovirus 9 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | rhinovirus A9 | 2 | organism-based format | Scientific Literature | ||
15. | ALA1663004 | F | Antiviral activity against Human poliovirus 3 strain Sabin infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | Poliovirus 3 | 2 | organism-based format | Scientific Literature | ||
16. | ALA1661043 | F | Antiviral activity against Human poliovirus 2 Sabin infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | Poliovirus 2 | 2 | organism-based format | Scientific Literature | ||
17. | ALA1661044 | F | Antiviral activity against Human poliovirus 1 strain Sabin infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | Poliovirus 1 | 2 | cell-based format | Scientific Literature | ||
18. | ALA1661045 | F | Antiviral activity against Human coxsackievirus A21 (strain Coe) infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | Human coxsackievirus A21 (strain Coe) | 2 | cell-based format | Scientific Literature | ||
19. | ALA1661046 | F | Antiviral activity against Coxsackievirus B3 (strain Nancy) infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | Coxsackievirus B3 (strain Nancy) | 2 | cell-based format | Scientific Literature | ||
20. | ALA1661047 | F | Antiviral activity against Human enterovirus 71 (strain BRCR) infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by MTS-based CPE reduction assay | Human enterovirus 71 (strain BRCR) | 2 | cell-based format | Scientific Literature |